Six years' follow-up after hepatitis A vaccination

被引：45

作者：

Werzberger, A ^{[1
]}

Kuter, B

Nalin, D

机构：

[1] Kiryal Joel Med Res Inst, Monroe, NY 10950 USA

[2] Merck Res Labs, W Point, PA USA

[3] Merck Vaccine Div, W Point, PA 19486 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1998年 / 338卷 / 16期

关键词：

D O I：

10.1056/NEJM199804163381615

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1160 / 1160

页数：1

共 4 条

[1]

Nalin David, 1995, Drugs of the Future, V20, P24

[2]

SMITH PF, 1997, J EPIDEMIOL INFECT, V118, P243

[3] HEPATITIS-A VIRUS-INFECTION IN HOUSEHOLDS [J].

VILLAREJOS, VM ;

SERRA, J ;

ANDERSONVISONA, K ;

MOSLEY, JW .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1982, 115 (04) :577-586

[4] A CONTROLLED TRIAL OF A FORMALIN-INACTIVATED HEPATITIS-A VACCINE IN HEALTHY-CHILDREN [J].

WERZBERGER, A ;

MENSCH, B ;

KUTER, B ;

BROWN, L ;

LEWIS, J ;

SITRIN, R ;

MILLER, W ;

SHOUVAL, D ;

WIENS, B ;

CALANDRA, G ;

RYAN, J ;

PROVOST, P ;

NALIN, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (07) :453-457

← 1 →